GlassScriptPhysician profile
Steven D Vath
NPI 1164441184
$3,256.72
in general payments reported to CMS, 2019-2025
14 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what 75% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $528 · 2020: $102 · 2021: $805 · 2022: $388 · 2023: $130 · 2024: $226 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,434.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $532.01 | 2019-2022 | |
| Allergan, INC. | $508.23 | 2019-2022 | |
| Davol INC. | $342.51 | 2022-2025 | Phasix Mesh |
| Motiva USA, LLC | $311.80 | 2024-2025 | |
| Integra Lifesciences Corporation | $259.02 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Abbvie INC. | $246.90 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Bard Peripheral Vascular, INC. | $246.30 | 2021 | |
| Galderma Laboratories, L.P. | $212.89 | 2019-2022 | |
| Becton, Dickinson and Company | $192.17 | 2025 | Phasix Mesh |
| Tela Bio, INC. | $172.50 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $158.07 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Merck Sharp & Dohme LLC | $32.96 | 2021-2023 | Bridion |
| Solta Medical, A Division of Bausch Health US, LLC | $24.37 | 2025 | |
| Innovation Technologies INC | $16.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Vath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.